BRAIN-INVOLVED MULTIPLE MYELOMA: STABILITY ACHIEVED WITH BENDAMUSTINE-POMALIDOMIDE, RADIOTHERAPY AND DARATUMUMAB-BASED THERAPY
Objective: Multiple myeloma is a plasma cell malignancy that mainly affects the bones and skeletal system. The involvement of the brain as a site is very rare; it usually takes place via calvarial lesions with intracranial extension and is considered resistant to treatment. This report presents the...
Saved in:
| Main Authors: | Bengisu Ece Duman, Büşra Akdoğan, Birol Güvenç |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | Hematology, Transfusion and Cell Therapy |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2531137924028669 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The multicenter experience with bendamustine in the treatment of relapsed and refractory multiple myeloma
by: S. V. Voloshin, et al.
Published: (2015-10-01) -
Pulmoner extramedullary hematopoiesis mimicking plasmacytoma in a patient with multiple myeloma candidate for autoHSCT
by: Serdar Sivgin
Published: (2014-08-01) -
New Approaches to Improving Bendamustine Microractor Synthesis
by: A. L. Moldavsky, et al.
Published: (2020-02-01) -
PHARMACOECONOMIC ANALYSIS OF THE USE OF RIBOMUSTIN® IN THERAPY OF THE FIRST LINE OF A MULTIPLE MYELOMA FOR PATIENTS MORE SENIOR 65 YEARS OLD
by: A. S. Kolbin, et al.
Published: (2015-03-01) -
The role of pomalidomide in treatment of relapse and refractory multiple myeloma
by: S. V. Voloshin, et al.
Published: (2022-01-01)